The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jun. 25, 2024
Filed:
Dec. 09, 2022
Applicant:
University of Washington, Seattle, WA (US);
Inventors:
Edward Clark, Seattle, WA (US);
Jay Wesley Chaplin, Seattle, WA (US);
Assignee:
UNIVERSITY OF WASHINGTON, Seattle, WA (US);
Primary Examiner:
Int. Cl.
CPC ...
A61K 47/40 (2006.01); A61K 39/12 (2006.01); A61K 39/29 (2006.01); A61K 39/385 (2006.01); A61K 47/68 (2017.01); C07K 16/28 (2006.01); C12N 7/00 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C12N 7/00 (2013.01); A61K 39/12 (2013.01); A61K 39/29 (2013.01); A61K 39/385 (2013.01); A61K 47/6811 (2017.08); A61K 47/6849 (2017.08); C07K 16/2896 (2013.01); A61K 2039/55511 (2013.01); A61K 2039/55561 (2013.01); A61K 2039/6056 (2013.01); C07K 2319/40 (2013.01); C07K 2319/74 (2013.01); C12N 2770/24132 (2013.01); C12N 2770/24134 (2013.01); C12N 2770/28033 (2013.01); Y02A 50/30 (2018.01);
Abstract
The present invention provides compositions of CD 180 targeting molecules coupled to heterologous antigens, and their use in treating and/or limiting disease.